113 related articles for article (PubMed ID: 9264710)
1. [Optimization of a method of infusion of reverse agonists of GABA-receptor complex in analysis of rapidly reversible effects of tranquilizers and ethanol].
Golovenko NIa; Zin'kovskiĭ VG; Zhuk OV; Stankevich EA; Fedorova EA; Pykhteev DM
Biull Eksp Biol Med; 1997 May; 123(5):551-4. PubMed ID: 9264710
[No Abstract] [Full Text] [Related]
2. [Effector modelling of the action of ligands of the GABA-receptor complex, cooperativity of the processes and the type of modification of the complex by convulsants and their reversible agonists].
Golovenko NIa; Zhuk OV; Zin'kovskiĭ VG
Biull Eksp Biol Med; 1989 Apr; 107(4):453-6. PubMed ID: 2541834
[TBL] [Abstract][Full Text] [Related]
3. [Comparative effects of tranquilizing and nootropic agents on development and functional disturbance of escape reaction].
Inozemtsev AN; Bokieva SB; Voronina TA; Tushmalova NA
Biull Eksp Biol Med; 1996 Aug; 122(8):152-5. PubMed ID: 9081464
[No Abstract] [Full Text] [Related]
4. [Effect of triftazin and haloperidol on the activity of phenazepam].
Molodavkin GM; Belousova SG
Biull Eksp Biol Med; 1983 Aug; 96(8):64-6. PubMed ID: 6882908
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological compatibility of the antineoplastic drugs ftorafur and 5-fluorouracil with the psychotropic drugs aminazine and phenazepam (an experimental study)].
Syrkin AB; Voronia TA; Mikhaĭlova LM; Suslov NI
Vestn Akad Med Nauk SSSR; 1984; (5):66-70. PubMed ID: 6429964
[No Abstract] [Full Text] [Related]
6. [The fenazepam demand by rats depending on the degree of alcoholic motivation].
Golovenko NIa; Surmak VV; Gurman EG; Karaseva TL
Farmakol Toksikol; 1988; 51(6):90-2. PubMed ID: 2906882
[TBL] [Abstract][Full Text] [Related]
7. [New evidence for a GABA-ergic component in the mechanism of action of benzodiazepine tranquilizers].
Zakusov VV; Ostrovskaia RU
Biull Eksp Biol Med; 1981 May; 91(5):571-4. PubMed ID: 6789910
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the effects of loprazolam and alcohol on psychomotor performance and memory in healthy subjects].
Hakkou F; Warot D; Jaouen C; Bensimon G; Simon P
Therapie; 1988; 43(1):51-6. PubMed ID: 2895966
[No Abstract] [Full Text] [Related]
9. [Stimulation of prostaglandin E2 and F2a biosynthesis in the brains of mouse strain F1 (CBA X C57BL) by the tranquilizer phenazepam].
Romantsev EF; Nikandrova TI; Zhulanova ZI; Bakhova AV
Dokl Akad Nauk SSSR; 1981; 258(1):239-42. PubMed ID: 6113922
[No Abstract] [Full Text] [Related]
10. [Effect of fenazepam on the ACTH content of the blood plasma in inbred mice under stress exposure].
Seredenin SB; Blednov IuA
Biull Eksp Biol Med; 1986 Dec; 102(12):724-6. PubMed ID: 3026513
[TBL] [Abstract][Full Text] [Related]
11. [Biokinetics of a new prodrug gidazepam and its metabolite].
Andronati SA; Zin'kovskiĭ VG; Totrova MIu; Golovenko NIa; Stankevich EA; Zhuk OV
Biull Eksp Biol Med; 1992 Jan; 113(1):45-7. PubMed ID: 1356504
[TBL] [Abstract][Full Text] [Related]
12. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
[TBL] [Abstract][Full Text] [Related]
13. [Multifactorial method for assessing the physical work capacity of mice].
Dubovik BV; Bogomazov SD
Farmakol Toksikol; 1987; 50(2):116-21. PubMed ID: 3582626
[TBL] [Abstract][Full Text] [Related]
14. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines.
Stanley JL; Lincoln RJ; Brown TA; McDonald LM; Dawson GR; Reynolds DS
J Psychopharmacol; 2005 May; 19(3):221-7. PubMed ID: 15888506
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the tranquilizing effect of phenazepam and mebicar in humans using a method of mean cortical evoked potential after perception of emotionally significant words].
Val'dman AV; Kostandov EA; Martynikhin AV
Biull Eksp Biol Med; 1983 Jan; 95(1):47-9. PubMed ID: 6830958
[No Abstract] [Full Text] [Related]
16. [Tranquilizers. Pharmacologic aspects].
Simon P
Encephale; 1976; 2(3):193-6. PubMed ID: 11091
[TBL] [Abstract][Full Text] [Related]
17. Loprazolam: an intermediate acting benzodiazepine. A review article.
Beaumont G
Br J Clin Pract; 1983 Sep; 37(9):307-10, 312. PubMed ID: 6138090
[No Abstract] [Full Text] [Related]
18. [Effect of tranquilizers on animal resistance to adequate stimulus exposure of the vestibular apparatus].
Maksimovich IaB; Khinchikashvili NV
Farmakol Toksikol; 1979; 42(6):606-10. PubMed ID: 40818
[TBL] [Abstract][Full Text] [Related]
19. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
20. [A reversible functional disorder of the escape reaction as a model for studying the effect of tranquilizers].
Inozemtsev AN; Bakieva SB; Voronina TA; Tushmalova NA
Eksp Klin Farmakol; 1996; 59(2):3-5. PubMed ID: 8974560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
